Tizanidine Tablet
Product Images NDC 63629-2370

5 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 63629-2370). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine-1 (Tizanidine 1)

Tizanidine-1 (Tizanidine 1)
Chemical structure of Tizanidine hydrochloride, showing the molecular arrangement including a chlorinated aromatic ring, thiazole ring, and imidazoline moiety, consistent with the active ingredient Tizanidine in the 2 mg tablet form by Bryant Ranch Prepack.*
FDA Label Image

Tizanidine-2 (Tizanidine 2)

Tizanidine-2 (Tizanidine 2)
A pharmacokinetic curve showing plasma tizanidine concentration (ng/mL) over time (hours) post-dosing. The graph compares four conditions: 4 mg tizanidine tablets with food, tablets without food, capsules with food, and capsules without food, indicating how food affects drug plasma levels over a 24-hour period.*
FDA Label Image

Tizanidine-3 (Tizanidine 3)

Tizanidine-3 (Tizanidine 3)
A line graph showing the improvement in Ashworth Score plotted against hours post-dose for three groups: 16 mg tizanidine, 8 mg tizanidine, and placebo. The graph includes error bars representing variability in the data at each time point between 0 and 6 hours.*
FDA Label Image

Tizanidine-4 (Tizanidine 4)

Tizanidine-4 (Tizanidine 4)
A line graph showing improvement in Ashworth Score over time with two treatments: tizanidine (mean dose 28.8 mg) and placebo. The x-axis labels study phases (End of Titration, End of Maintenance, Endpoint) and the y-axis displays improvement scores from -6 to 2. Data points for tizanidine indicate greater improvement with error bars, compared to placebo.*
FDA Label Image

Label (Lbl636292370)

Label (Lbl636292370)
Label for Tizanidine Tablets USP 2 mg oral tablets, relabeled by Bryant Ranch Prepack, Inc. The label shows the NDC 63629-2370-1 and indicates a package size of 1000 tablets. Storage instructions specify controlled room temperature, and dispensing in a child-resistant container. The label features the BRP Pharmaceuticals logo and states 'Rx only.'*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.